Is JPM worth it? As the buzzy conference dies down, debate on its value rumbles on
The exorbitant cost of attending JPMorgan — from hotels and flights to coffee and meeting space — has long been a talking point for biopharma execs gathering in San Francisco every January. But as the industry’s signature networking confab fades out, the age-old question is once again in focus: Is it all worthwhile?
In a reflective article bemoaning the conference’s value and a negative stream of “excesses,” Bruce Booth of Atlas Venture gave an emphatic answer: No.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.